Pulmonary complications in liver disease

被引：1

作者：

Sen, Sambit ^{[1
]}

Alexander, Graeme J. M. ^{[1
]}

机构：

[1] Cambridge Univ Hosp NHS Fdn Trust, Dept Hepatol, Cambridge CB2 0QQ, England

来源：

BRITISH JOURNAL OF HOSPITAL MEDICINE | 2009年 / 70卷 / 12期

关键词：

SEVERE PORTOPULMONARY HYPERTENSION; LUNG PERFUSION SCAN; HEPATOPULMONARY-SYNDROME; ARTERIAL-HYPERTENSION; NITRIC-OXIDE; RISK-FACTORS; TRANSPLANTATION; HEMODYNAMICS; EPOPROSTENOL; SILDENAFIL;

D O I：

10.12968/hmed.2009.70.12.45504

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary complications of liver disease are poorly understood and often identified late. Abnormalities of the pulmonary vasculature lead to two distinct complications, hepatopulmonary syndrome and portopulmonary hypertension, which differ in their clinical features and management. This article focuses on these two entities.

引用

页码：685 / 691

页数：7

共 49 条

[1] DIAGNOSTIC UTILITY OF CONTRAST ECHOCARDIOGRAPHY AND LUNG PERFUSION SCAN IN PATIENTS WITH HEPATOPULMONARY SYNDROME [J].

ABRAMS, GA ;

JAFFE, CC ;

HOFFER, PB ;

BINDER, HJ ;

FALLON, MB .

GASTROENTEROLOGY, 1995, 109 (04) :1283-1288

[2] Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: A new approach [J].

Abrams, GA ;

Nanda, NC ;

Dubovsky, EV ;

Krowka, MJ ;

Fallon, MB .

GASTROENTEROLOGY, 1998, 114 (02) :305-310

[3] Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation [J].

Arguedas, MR ;

Abrams, GA ;

Krowka, MJ ;

Fallon, MB .

HEPATOLOGY, 2003, 37 (01) :192-197

[4] Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension [J].

Austin, Mark J. ;

McDougall, Neil I. ;

Wendon, Julia A. ;

Sizer, Elizabeth ;

Knisely, Alex S. ;

Rela, Mohammed ;

Wilson, Carol ;

Callender, Michael E. ;

O'Grady, John G. ;

Heneghan, Michael A. .

LIVER TRANSPLANTATION, 2008, 14 (03) :287-291

[5] N-Terminal Brain Natriuretic Peptide as a Diagnostic Test in Cirrhotic Patients With Pulmonary Arterial Hypertension [J].

Bernal, V. ;

Pascual, I. ;

Esquivias, P. ;

Garcia-Gil, A. ;

Mateo, J. M. ;

Lacambra, I. ;

Serrano, M. T. ;

Simon, M. A. .

TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) :987-988

[6] ARTERIAL CHANGES IN LUNGS IN CIRRHOSIS OF LIVER - LUNG SPIDER NEVI [J].

BERTHELO.P ;

WALKER, JG ;

SHERLOCK, S ;

REID, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (06) :291-&

[7] Portopulmonary hypertension - A tale of two circulations [J].

Budhiraja, R ;

Hassoun, PM .

CHEST, 2003, 123 (02) :562-576

[8] Haemodynamic evaluation of pulmonary hypertension [J].

Chemla, D ;

Castelain, V ;

Hervé, P ;

Lecarpentier, Y ;

Brimioulle, S .

EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) :1314-1331

[9] ELEVATED EXHALED NITRIC-OXIDE IN PATIENTS WITH HEPATOPULMONARY SYNDROME [J].

CREMONA, G ;

HIGENBOTTAM, TW ;

MAYORAL, V ;

ALEXANDER, G ;

DEMONCHEAUX, E ;

BORLAND, C ;

ROE, P ;

JONES, GJ .

EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (11) :1883-1885

[10] Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression [J].

De, BK ;

Sen, S ;

Biswas, PK ;

Mandal, SK ;

Das, D ;

Das, U ;

Guru, S ;

Bandyopadhyay, K .

GASTROENTEROLOGY, 2002, 122 (04) :897-903

← 1 2 3 4 5 →